Sage Capital Advisors,Llc Amicus Therapeutics, Inc. Transaction History

Sage Capital Advisors,Llc

$374 Million
Q3 2024

A detailed history of Sage Capital Advisors,Llc transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Sage Capital Advisors,Llc holds 10,400 shares of FOLD stock, worth $100,672. This represents 0.03% of its overall portfolio holdings.

Number of Shares

10,400

Previous 10,400 -0.0%

Holding current value

$100,672

Previous $103,000 7.77%

% of portfolio

0.03%

Previous 0.03%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 09, 2024	BUY	$9.04 - $11.75 $94,015 - $122,200	10,400 New	10,400 $103,000
Q3 2022 Oct 17, 2022	SELL	$9.82 - $12.75 $5,892 - $7,650	-600 Reduced 5.26%	10,800 $113,000
Q2 2022 Jul 06, 2022	SELL	$6.23 - $11.12 $2,803 - $5,004	-450 Reduced 3.8%	11,400 $122,000
Q1 2022 Apr 11, 2022	BUY	$7.89 - $12.48 $93,496 - $147,888	11,850 New	11,850 $103,000
Q4 2021 Jan 20, 2022	SELL	$9.82 - $12.44 $106,547 - $134,974	-10,850 Closed	0 $0
Q3 2021 Oct 26, 2021	BUY	$8.74 - $11.84 $94,829 - $128,464	10,850 New	10,850 $104,000
Q1 2020 Apr 17, 2020	SELL	$6.63 - $11.16 $67,626 - $113,832	-10,200 Closed	0 $0
Q4 2019 Jan 16, 2020	BUY	$7.48 - $10.75 $76,296 - $109,650	10,200 New	10,200 $99,000
Q3 2019 Oct 17, 2019	SELL	$8.02 - $13.25 $81,804 - $135,150	-10,200 Closed	0 $0
Q2 2019 Jul 31, 2019	SELL	$10.96 - $14.4 $21,920 - $28,800	-2,000 Reduced 16.39%	10,200 $135,000
Q1 2019 Apr 23, 2019	SELL	$10.04 - $13.92 $2,007 - $2,784	-200 Reduced 1.61%	12,200 $166,000
Q4 2018 Feb 11, 2019	BUY	$8.38 - $13.44 $12,570 - $20,160	1,500 Added 13.76%	12,400 $119,000
Q3 2018 Nov 14, 2018	BUY	$11.6 - $16.54 $8,120 - $11,578	700 Added 6.86%	10,900 $132,000
Q2 2018 Aug 14, 2018	SELL	$13.13 - $17.09 $6,565 - $8,545	-500 Reduced 4.67%	10,200 $159,000
Q1 2018 May 01, 2018	SELL	$13.76 - $17.12 $6,880 - $8,560	-500 Reduced 4.46%	10,700 $161,000
Q4 2017 Feb 14, 2018	BUY	$12.51 - $16.24 $12,510 - $16,239	1,000 Added 9.8%	11,200 $161,000
Q3 2017 Nov 30, 2017	BUY	$11.74 - $15.78 $119,748 - $160,956	10,200	10,200 $154,000

Others Institutions Holding FOLD

# of Institutions

311

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.72B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Capital Advisors,Llc, based on Form 13F filings with the SEC.

News

Stay updated on Sage Capital Advisors,Llc with notifications on news.

Account

Sage Capital Advisors,Llc Amicus Therapeutics, Inc. Transaction History